Payment overview · 2025
General Payments
$20.30
1 reported records · 1 companies
Healthcare provider profile · identity verified
Patrick Joseph Brown, MD
Allopathic & Osteopathic Physicians|Family Medicine · SCOTTSBLUFF, NE · NPI 1023025533
Verified facts
What the public records show
CMS Open Payments records show Patrick Joseph Brown, MD received $20.30 in general payments during 2025 across 1 reported records.
Abbott Laboratories accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Abbott Laboratories | Unresolved — no canonical attribution shown | $20.30 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $20.30 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| FREESTYLE LIBRE 3 Normalized: freestyle libre 3 |
Device | Abbott Laboratories | $20.30 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 601 | 148 |
| Levothyroxine Sodium | Levothyroxine Sodium | 525 | 110 |
| Amlodipine Besylate | Amlodipine Besylate | 506 | 114 |
| Omeprazole | Omeprazole | 495 | 119 |
| Lisinopril | Lisinopril | 430 | 95 |
| Metformin Hcl | Metformin Hcl | 376 | 80 |
| Furosemide | Furosemide | 365 | 73 |
| Eliquis | Apixaban | 269 | 32 |
| Metoprolol Succinate | Metoprolol Succinate | 267 | 60 |
| Meloxicam | Meloxicam | 254 | 65 |
| Potassium Chloride | Potassium Chloride | 234 | 39 |
| Simvastatin | Simvastatin | 210 | 43 |
| Sertraline Hcl | Sertraline Hcl | 208 | 37 |
| Pravastatin Sodium | Pravastatin Sodium | 192 | 48 |
| Tamsulosin Hcl | Tamsulosin Hcl | 188 | 45 |
| Pantoprazole Sodium | Pantoprazole Sodium | 184 | 41 |
| Fluticasone Propionate | Fluticasone Propionate | 177 | 44 |
| Hydrochlorothiazide | Hydrochlorothiazide | 176 | 45 |
| Allopurinol | Allopurinol | 174 | 37 |
| Jardiance | Empagliflozin | 166 | 17 |
| Losartan Potassium | Losartan Potassium | 166 | 45 |
| Glipizide | Glipizide | 160 | 40 |
| Gabapentin | Gabapentin | 155 | 32 |
| Metoprolol Tartrate | Metoprolol Tartrate | 154 | 34 |
| Tramadol Hcl | Tramadol Hcl | 143 | 37 |
| Diclofenac Sodium | Diclofenac Sodium | 141 | 31 |
| Duloxetine Hcl | Duloxetine Hcl | 132 | 21 |
| Lorazepam | Lorazepam | 105 | 22 |
| Prednisone | Prednisone | 102 | 71 |
| Ozempic | Semaglutide | 99 | 13 |
| Montelukast Sodium | Montelukast Sodium | 94 | 23 |
| Alendronate Sodium | Alendronate Sodium | 92 | 20 |
| Clopidogrel | Clopidogrel Bisulfate | 86 | 20 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 84 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 82 | 15 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 75 | 18 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 72 | 29 |
| Pregabalin | Pregabalin | 69 | 12 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 69 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 68 | suppressed |
| Spironolactone | Spironolactone | 68 | 15 |
| Breo Ellipta | Fluticasone/Vilanterol | 66 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 66 | 18 |
| Carvedilol | Carvedilol | 65 | 17 |
| Donepezil Hcl | Donepezil Hcl | 63 | 11 |
| Quetiapine Fumarate | Quetiapine Fumarate | 63 | suppressed |
| Bumetanide | Bumetanide | 62 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 61 | 25 |
| Memantine Hcl | Memantine Hcl | 61 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 60 | suppressed |
| Trazodone Hcl | Trazodone Hcl | 58 | 17 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 57 | 16 |
| Pioglitazone Hcl | Pioglitazone Hcl | 56 | 11 |
| Escitalopram Oxalate | Escitalopram Oxalate | 54 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 54 | 14 |
| Meclizine Hcl | Meclizine Hcl | 52 | suppressed |
| Valsartan | Valsartan | 51 | suppressed |
| Xarelto | Rivaroxaban | 49 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 48 | 12 |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 47 | 37 |
| Synthroid | Levothyroxine Sodium | 46 | 11 |
| Farxiga | Dapagliflozin Propanediol | 45 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 44 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 43 | 35 |
| Cephalexin | Cephalexin | 42 | 27 |
| Ropinirole Hcl | Ropinirole Hcl | 42 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 41 | 41 |
| Atenolol | Atenolol | 41 | suppressed |
| Famotidine | Famotidine | 41 | suppressed |
| Finasteride | Finasteride | 41 | suppressed |
| Telmisartan | Telmisartan | 41 | 12 |
| Valacyclovir | Valacyclovir Hcl | 41 | 11 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 40 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 39 | suppressed |
| Clonazepam | Clonazepam | 38 | suppressed |
| Celecoxib | Celecoxib | 37 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 36 | suppressed |
| Dutasteride | Dutasteride | 35 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 35 | suppressed |
| Rybelsus | Semaglutide | 35 | suppressed |
| Estradiol | Estradiol | 34 | 13 |
| Glimepiride | Glimepiride | 34 | suppressed |
| Sucralfate | Sucralfate | 34 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 34 | suppressed |
| Baclofen | Baclofen | 31 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 31 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 31 | suppressed |
| Latanoprost | Latanoprost | 30 | suppressed |
| Topiramate | Topiramate | 30 | suppressed |
| Alprazolam | Alprazolam | 29 | suppressed |
| Lubiprostone | Lubiprostone | 29 | suppressed |
| Ketoconazole | Ketoconazole | 28 | 14 |
| Lactulose | Lactulose | 28 | suppressed |
| Chlorthalidone | Chlorthalidone | 27 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 27 | suppressed |
| Digoxin | Digoxin | 27 | suppressed |
| Januvia | Sitagliptin Phosphate | 27 | suppressed |
| Mirtazapine | Mirtazapine | 27 | suppressed |
| Nifedipine Er | Nifedipine | 27 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 27 | suppressed |
| Carbamazepine Er | Carbamazepine | 26 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 25 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 25 | suppressed |
| Boostrix Tdap | Diphth,pertuss(Acell),tet Vac | 24 | 24 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 24 | suppressed |
| Verapamil Er | Verapamil Hcl | 24 | suppressed |
| Diazepam | Diazepam | 23 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 22 | suppressed |
| Ezetimibe | Ezetimibe | 22 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 22 | suppressed |
| Glipizide Er | Glipizide | 21 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 20 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 20 | suppressed |
| Lamotrigine | Lamotrigine | 20 | suppressed |
| Levetiracetam | Levetiracetam | 20 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 20 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 19 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 19 | suppressed |
| Ibuprofen | Ibuprofen | 19 | suppressed |
| Lovastatin | Lovastatin | 19 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 19 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 19 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 19 | suppressed |
| Potassium Citrate Er | Potassium Citrate | 19 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 19 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 18 | suppressed |
| Methimazole | Methimazole | 18 | suppressed |
| Methotrexate | Methotrexate Sodium | 18 | suppressed |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 18 | suppressed |
| Fluconazole | Fluconazole | 17 | 14 |
| Metformin Hcl Er | Metformin Hcl | 17 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 17 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 16 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 16 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 16 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 16 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 16 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 16 | suppressed |
| Haloperidol | Haloperidol | 16 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 16 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 16 | 15 |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 16 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 16 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 15 | 12 |
| Azithromycin | Azithromycin | 15 | suppressed |
| Paroxetine Cr | Paroxetine Hcl | 15 | suppressed |
| Teriflunomide | Teriflunomide | 15 | suppressed |
| Acyclovir | Acyclovir | 14 | suppressed |
| Amoxicillin | Amoxicillin | 14 | 11 |
| Bupropion Hcl Sr | Bupropion Hcl | 14 | suppressed |
| Hydromorphone Hcl | Hydromorphone Hcl | 14 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 14 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 14 | suppressed |
| Ramipril | Ramipril | 14 | suppressed |
| Risperidone | Risperidone | 14 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 14 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 14 | suppressed |
| Aripiprazole | Aripiprazole | 13 | suppressed |
| Bupropion Xl | Bupropion Hcl | 13 | suppressed |
| Lithium Carbonate Er | Lithium Carbonate | 13 | suppressed |
| Nitroglycerin | Nitroglycerin | 13 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 13 | suppressed |
| Temazepam | Temazepam | 13 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 12 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 12 | 11 |
| Clonidine Hcl | Clonidine Hcl | 12 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 12 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 12 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 12 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 12 | suppressed |
| Aspirin-Dipyridamole Er | Aspirin/Dipyridamole | 11 | suppressed |
| Cilostazol | Cilostazol | 11 | suppressed |
| Eszopiclone | Eszopiclone | 11 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 11 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 11 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 11 | suppressed |
| Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 11 | suppressed |
| Trulicity | Dulaglutide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $20.30 · 1 records | Abbott Laboratories | FREESTYLE LIBRE 3 | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error